Literature DB >> 12509997

High yield expression and single-step purification of Toxoplasma gondii SAG1, GRA1, and GRA7 antigens in Escherichia coli.

Elzbieta Hiszczyńska-Sawicka1, Anna Brillowska-Dabrowska, Sławomir Dabrowski, Halina Pietkiewicz, Przemysław Myjak, Józef Kur.   

Abstract

This report describes a simple, highly efficient and reproducible method for obtaining large quantities of highly pure recombinant Toxoplasma gondii antigens, which can be used for diagnostic application. The obtained T. gondii SAG1, GRA1, and GRA7 antigens (as fusion proteins), expressed in Escherichia coli, contained polyhistidine tags at the N- and C-ends that allowed single-step isolation by metal-affinity chromatography on Ni(2+)-IDA-Sepharose columns. The immunoreactivity of the recombinant antigens was tested in an enzyme-linked immunosorbent assay (ELISA) format for potential application in the serodiagnosis of T. gondii infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509997     DOI: 10.1016/s1046-5928(02)00593-4

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  16 in total

1.  Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.

Authors:  Lucyna Holec; Elzbieta Hiszczyńska-Sawicka; Artur Gasior; Anna Brillowska-Dabrowska; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  MIC1-MAG1-SAG1 chimeric protein, a most effective antigen for detection of human toxoplasmosis.

Authors:  Lucyna Holec-Gasior; Bartlomiej Ferra; Dorota Drapala
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

3.  Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis.

Authors:  H Pietkiewicz; E Hiszczyńska-Sawicka; J Kur; E Petersen; H V Nielsen; M Paul; M Stankiewicz; P Myjak
Journal:  Parasitol Res       Date:  2006-08-08       Impact factor: 2.289

4.  Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis.

Authors:  H Pietkiewicz; E Hiszczyńska-Sawicka; J Kur; E Petersen; H V Nielsen; M Stankiewicz; I Andrzejewska; P Myjak
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

5.  GRA2 and ROP1 recombinant antigens as potential markers for detection of Toxoplasma gondii-specific immunoglobulin G in humans with acute toxoplasmosis.

Authors:  Lucyna Holec-Gasior; Józef Kur; Elzbieta Hiszczyńska-Sawicka
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

Review 6.  Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection.

Authors:  Ali Rostami; Panagiotis Karanis; Shirzad Fallahi
Journal:  Infection       Date:  2018-01-12       Impact factor: 3.553

Review 7.  Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies.

Authors:  Lucyna Holec-Gasior
Journal:  Clin Vaccine Immunol       Date:  2013-06-19

8.  Analysis of clonal type-specific antibody reactions in Toxoplasma gondii seropositive humans from Germany by peptide-microarray.

Authors:  Pavlo Maksimov; Johannes Zerweck; Aline Maksimov; Andrea Hotop; Uwe Gross; Katrin Spekker; Walter Däubener; Sandra Werdermann; Olaf Niederstrasser; Eckhardt Petri; Marc Mertens; Rainer G Ulrich; Franz J Conraths; Gereon Schares
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections.

Authors:  Mina Selseleh; Hossein Keshavarz; Mehdi Mohebali; Saeedeh Shojaee; Monavar Selseleh; Mohammad Reza Eshragian; Fatemeh Mansouri; Mohammad Hossein Modarressi
Journal:  Korean J Parasitol       Date:  2012-08-13       Impact factor: 1.341

10.  Production and Evaluation of Toxoplasma gondii Recombinant Surface Antigen 1 (SAG1) for Serodiagnosis of Acute and Chronic Toxoplasma Infection in Human Sera.

Authors:  M Mina Selseleh; H Keshavarz; M Mohebali; S Shojaee; Mh Modarressi; Mr Eshragian; M Monavar Selseleh
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.